This is why it's beneficial for these organizations to adopt digital signatures, and why so many of them already have.
San Francisco, CA (PRWEB) May 11, 2010
ARX (Algorithmic Research), a leading provider of digital signature solutions, is proud to announce its partnership with Montrium, a consulting group that delivers validation services for organizations within the Life Sciences industry.
Montrium has developed both custom and pre-defined validation packages that can be delivered for ARX's CoSign digital signature installations both as a stand-alone solution and when integrated with other systems, such as Microsoft® SharePoint®. These tried and tested validation packages match the various document types and workflows used by Life Science organizations including clinical research organizations (CROs) and biopharma companies, and enable these organizations to quickly and easily validate CoSign to meet 21 CFR Part 11 and other regulatory requirements.
"Organizations in the Life Sciences industry are being urged to shift to electronic processes, especially in regard to submissions to regulatory authorities," explains Paul Fenton, VP Pharmaceutical Processes and Technology, Montrium. "This is why it's beneficial for these organizations to adopt digital signatures, and why so many of them already have."
CoSign digital signature use in Life Sciences extends across departments and applications, from Standard Operating Procedures (SOPs) and investigator portals to electronic submissions and secure document exchange with external parties and partners. As such, CoSign is the most widely deployed digital signature solution in the Life Sciences industry, and is used by 1/3 of the 25 largest Pharmaceutical companies and six of the top 10 CROs in thousands of FDA GxP regulated applications.
"By teaming up with Montrium, ARX customers are able to qualify CoSign using proven validation scripts without having to create them from scratch in-house," said Rodd Schlerf, FDA and USDA Markets Manager, ARX.
Learn more about CoSign digital signatures for Bio-Pharma.
About CoSign Digital Signatures in Life Sciences
ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as life sciences, healthcare, government, engineering, and energy. ARX's CoSign digital signature solution fully automates approval workflows, allowing organizations to go paperless, expedite business processes, and eliminate the expenses and time allocations that paper-based signatures require. CoSign is the most widely-deployed digital signature solution in the Life Sciences industry, employed by over 10,000 FDA-regulated organizations including 5 of the top 10 Pharmaceuticals and 4 of the top 10 CROs. Via its standards-based underpinnings, the CoSign digital signature solution ensures signer intent, document integrity and compliance, while significantly streamlining business processes. CoSign creates a truly collaborative environment for the multiple parties involved in the Life Sciences ecosystem, enabling trust of electronic documentation spanning geographic locations and across organizations. Watch a Digital Signatures for Life Sciences video to learn how life sciences organizations can benefit from CoSign.
Montrium is a knowledge-based company providing high-quality services to the life sciences industry, effectively combining pharmaceutical sciences and technologies. Through its consortium of expert consultants, Montrium offers guidance and expertise to life sciences companies in order to improve research and development processes in the areas of strategic technology management for GxP environments, process design and optimization as well as GxP compliance and quality system management.
For more information please visit http://www.montrium.com.
CoSign is a registered trademark and CoSign PSF is a trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.
# # #